FDA Panel Recommends Approval Of Lilly's Prasugrel

and Drug Administration panel Tuesday unanimously recommended the agency approve prasugrel, a proposed anticlotting drug being developed by Eli Lilly and Co. (LLY) and Daiichi Sankyo Co. (4568. TO) , with warnings about bleeding risks. Prasugrel is...